Integramed (INMD) Sees Modest Delays in Bringing Some Operations to Market; Guides Q3, Q4
Tweet Send to a Friend
Integramed(R) (Nasdaq: INMD) sees Q3 sales ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
